Friday, August 02, 2013. Last Update: Fri 11:00 AM EST

Tags

Big Pharma

Audit Notes: Hiltzik on Drug R&D, A 1 Percent “Score”, Paywalls

The Los Angeles Times's Michael Hiltzik finds a study that questions the drug lobby's line on how much it costs... More

avandia.jpg

Audit Notes: WaPo on Avandia, giving away the store, plutocrats

Report shows how drug research is corrupted by corporate money

The Washington Post's Peter Whoriskey has another outstanding story in his series on the Avandia drug scandal at GlaxoSmithKline and... More

armies.jpg

Big Pharma’s army of messengers

A campaign to kill a drug discount

As we report in a companion piece here on CJR.org--"Medicare uncovered: What's not on the table"--the president's budget proposal,... More

DrugManufacturing.jpg

Flash: this new drug is not so new

Disappointing coverage of Brisdelle, the hot flash drug, misses a chance to expose one of Big Pharma’s oldest tricks

It seems we are going soft on Pharma these days, if coverage of the FDA marketing clearance of the drug... More

pills.jpg

Journalists’ guide to clinical guidelines

Reporters may get more than they bargain for when they rely on clinical practice guidelines as sources

We may all be in trouble if, as he suggests in a recent New York Times op-ed, Dr. Jerry Avorn... More

Old TNR vs. New TNR

In one tweet

Luke Russert is the Golden Boy of DC

And it drives young journalists crazy

Oh, #Florida!

Why does Florida produce so much weird news? Experts explain

Beijing subway at rush hour

Feel better about your commute now?

  • If you like the magazine, get the rest of the year for just $19.95 (6 issues in all).
  • If not, simply write cancel on the bill and return it. You will owe nothing.

Who Owns What

The Business of Digital Journalism

A report from the Columbia University Graduate School of Journalism

Study Guides

Questions and exercises for journalism students.